Evidence map›Paper›PMID 33150263›Full record

ArticleJMA journal2020

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (

Hiroshi Yokomichi, Takashi Inozume, Makoto Wada, Jun Asai, Hiroshi Igaki, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Hiroshi Koga and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMA journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hiroshi YokomichiDepartment of Health Sciences, University of Yamanashi, Chuo, Japan.
Takashi InozumeDepartment of Dermatology, University of Yamanashi, Chuo, Japan.
Makoto WadaDepartment of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Jun AsaiDepartment of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hiroshi IgakiDepartment of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Kenjiro NamikawaDepartment of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ayato HayashiDepartment of Plastic and Reconstructive Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan.
Satoshi FukushimaDepartment of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Taku FujimuraDepartment of Dermatology, Tohoku University, Sendai, Japan.
Hiroshi KogaDepartment of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
Yasuhiro NakamuraDepartment of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Hidaka, Japan.
Mie MochizukiDepartment of Pediatrics, University of Yamanashi, Chuo, Japan.
Zentaro YamagataDepartment of Health Sciences, University of Yamanashi, Chuo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAF mutationBRAFV600Edisagreementmelanomametastasismitogen-activated protein kinase kinase inhibitorprimary tumorserine-threonine protein kinase BRAF inhibitor

Identifiers

PMID33150263
PMCPMC7590371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.